Tyrosinase, also known as monophenol monooxygenase or EC 1.14.18.1, is a copper-containing enzyme that plays a crucial role in the biosynthesis of melanin, the pigment responsible for coloration in animals, including humans. It catalyzes the rate-limiting steps in melanin production, which involve the oxidation of the amino acid tyrosine to L-DOPA (L-3,4-dihydroxyphenylalanine), and further oxidation of L-DOPA to dopaquinone. These reactions are the initial steps in the formation of both eumelanin (brown-black pigment) and pheomelanin (reddish-yellow pigment). The enzyme is primarily found in melanocytes, specialized cells located in the bottom layer of the skin's epidermis, hair follicles, and the iris of the eyes.
According to the new market research report “Tyrosinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”, published by QYResearch, the global Tyrosinase market size is projected to reach USD 16 million by 2030, at a CAGR of 6.4% during the forecast period.
- Global Tyrosinase MarketSize(US$ Million), 2019-2030
Source: QYResearch, "Tyrosinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
- Global Tyrosinase Top12Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)
Source: QYResearch, "Tyrosinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
According to QYResearch Top Players Research Center, the global key manufacturers of Tyrosinase include Merck, RayBiotech, Leica Biosystems, BIO SB, Sinopharm Chemical Reagent, Innovative Research, Glentham Life Sciences, Enzo Biochem, Beijing Baiaolaibo, Aladdin, etc. In 2023, the global top 10 players had a share approximately 68.0% in terms of revenue.
Market Drivers:
One of the primary drivers of the tyrosinase market is its use in the cosmetics industry, particularly in skin-lightening and anti-aging products. Consumers' increasing demand for natural and safe skin-whitening agents has fueled the need for tyrosinase inhibitors, which can regulate melanin production and address hyperpigmentation issues.
In the pharmaceutical sector, tyrosinase inhibitors are being researched for their potential in treating skin disorders like melasma, vitiligo, and even skin cancers related to abnormal melanin production. This medical application presents a significant growth opportunity as research advances.
Tyrosinase is used as a biomarker for certain diseases, such as mushroom poisoning (due to certain toxic mushrooms containing high levels of tyrosinase) and genetic disorders affecting pigmentation. Its diagnostic applications are an emerging field that could expand market opportunities.
Continuous R&D for more effective and safer tyrosinase inhibitors, both natural and synthetic, opens up opportunities for new product launches in the cosmetic and pharmaceutical sectors.
With consumers leaning towards eco-friendly and naturally derived products, there's a growing market for tyrosinase inhibitors sourced from natural extracts, such as plants and fungi. These ingredients cater to the increasing demand for clean-label products.
Restraint:
In cosmetic applications, particularly in skin whitening products, regulations can be stringent due to safety concerns. The use of tyrosinase inhibitors or modulators needs to pass through rigorous testing and approval processes, which can be time-consuming and costly.
Maintaining the stability and efficiency of tyrosinase in formulations is challenging. Exposure to heat, light, and certain chemicals can degrade the enzyme, reducing its effectiveness. This requires constant innovation in formulation technology to ensure product efficacy.
The production of recombinant tyrosinase or extraction from natural sources can be expensive. Balancing cost-effectiveness with maintaining high-quality standards is a significant challenge for manufacturers.
With advancements in technology, synthetic alternatives and plant-based extracts are emerging as competitors to tyrosinase-based products. These alternatives might offer similar or better efficacy with fewer side effects or regulatory hurdles.
Trend:
In the cosmetics sector, tyrosinase inhibitors are highly sought after for their ability to reduce melanin production, leading to skin lightening and spot reduction products. Natural ingredients with tyrosinase inhibitory properties, such as arbutin, kojic acid, and licorice extract, have gained popularity due to increasing consumer demand for safer and more eco-friendly skincare options. The trend towards developing novel and efficacious tyrosinase inhibitors continues, with a focus on sustainability and minimizing side effects.
In medical applications, tyrosinase is being researched for its potential in treating disorders related to pigmentation, such as vitiligo and hyperpigmentation conditions. Additionally, it has implications in understanding and managing certain genetic diseases like albinism, where malfunctioning tyrosinase can lead to a complete or partial lack of pigmentation. Research into gene therapies targeting tyrosinase-related pathways is an emerging trend.
Advances in biotechnology have enabled the development of recombinant tyrosinases, which offer improved specificity, stability, and efficiency compared to their natural counterparts. These engineered enzymes find applications in biocatalysis, biosensors, and even in environmental remediation processes where they can help break down pollutants. The trend towards customization of tyrosinase for specific industrial needs is gaining momentum.
As with any ingredient used in consumer products, regulations surrounding the use of tyrosinase and its inhibitors are evolving. There is a growing emphasis on safety assessments, ethical sourcing, and clear labeling, especially in response to consumer concerns about product safety and environmental impact. Regulatory bodies worldwide are continuously updating guidelines to ensure the safe and effective use of tyrosinase-based products.
About The Authors
Yin Hang
Lead Author
Email: yinhang@qyresearch.com
Tel: +86-18310165532
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)
EN: https://www.qyresearch.com
JP: https://www.qyresearch.co.jp